This page has been automatically translated. If there is any discrepancy, the English version is authoritative.

Revised: July 16, 2026

LDL “BAD” Cholesterol: Apolipoprotein B, Imaging Resolution, and the Illusion of “Normal” Coronary Arteries at Age 60

By: Peter Megdal PhD

How to Use This Article

Medical disclaimer: This article is for education only and is not medical advice. Always consult your clinician for personal guidance.

Easy Read

The Mystery of the “Perfect” 60-Year-Old

Imagine a man named John who just turned 60. John feels great. He goes for walks, eats his greens, and can still keep up with his grandkids. He recently went to his doctor for a big check-up. The doctor looked at his charts, checked his blood pressureBlood pressure is the force of blood pushing against your artery walls. It is written as two numbers, like 120/80. The top number is the pressure when your heart squeezes, the bottom is when it relaxes., and gave him a “normal” report. His tests didn’t show any big clogs, and his cholesterolCholesterol is a waxy substance your body needs. It goes into cell walls, hormones, vitamin D, and the bile that digests your food. You would die without it. numbers looked “fine.” John left the office feeling like he had the heart of a teenager.

However, John might be caught in “The Check-up Mystery.” This is a situation where the tests look good on the surface, but the reality inside the body is much different.

Think of it like an old house built 60 years ago. From the sidewalk, the house looks amazing. It has a fresh coat of bright paint and a perfect lawn. But if you were to rip open the walls, you might find old, rusty pipes and wires that are starting to fray. The house looks “normal” to anyone passing by, but the structure is aging deep where no one can see.

This post is here to show you why common heart tests often miss the “hidden” dangers of heart disease. We are going to look at why a clean bill of health might just be a trick and what the science really says about our arteries as we grow older.

Takeaway 1: Your Arteries Started Aging When You Were a Teenager

Most people think heart disease is an “old person” problem. They believe that if they are 30 or 40 years old, their arteries are “perfectly clean under a microscope.” But medical research shows a very different, and much more honest, story.

There is a huge gap between what a doctor sees on a standard test (which we call Clinical Reality) and what a scientist sees when they look at the body’s tissues directly (which we call Forensic Reality). Scientists have looked at the arteries of teenagers and young adults who passed away in accidents. Two famous studies, the “PDAYPDAY, short for Pathobiological Determinants of Atherosclerosis in Youth, examined the arteries of young people aged 15 to 34 who died of other causes.” study and the “Bogalusa Heart StudyThe Bogalusa Heart Study examined the arteries of children and young adults who died in accidents in a Louisiana town.,” found something that should change how we think about our health.

Almost all of those teenagers already had the very first signs of heart disease. Scientists call these “fatty streaks.” These are tiny yellow piles of fat that start to build up in the lining of the heart’s pipes.

Analysis and Reflection: It is a shock to realize that “perfect” arteries basically do not exist in the Western world by the time someone reaches age 40. We spend our lives thinking we are starting with a clean slate every time we go for a run or eat a salad. But the “trash” has been piling up since we were in high school. By the time someone is 60, the idea that their arteries are “undamaged” is almost always a mistake made by tests that just aren’t powerful enough. As the experts say:

“By the sixth decade of life, perfectly clean coronary arteries are virtually absent in Western populations.”

Takeaway 2: LDL is the Wrong Way to Count Your Risk

When you get a blood test, your doctor usually looks at “LDL-C.” This measures the weight of the “bad” cholesterol in your blood. But science is finding that weight isn’t the best way to measure danger. Instead, we should be looking at “ApoBApoB is a protein that sits on the outside of every cholesterol particle that can get stuck in your artery wall and cause plaque. Each of those particles carries exactly one ApoB..”

To understand this, let’s use an analogy of suitcases and passengers.

Imagine a doorway (your arteryAn artery is a blood vessel that carries blood away from the heart to the rest of the body. wall). LDL-C is like the total weight of all the luggage coming through the airport. But ApoB is the actual number of suitcases. It doesn’t matter if a suitcase is heavy or light; if there are too many suitcases, they are going to get stuck in the doorway and cause a pile-up.

Every single “bad” particle that causes heart disease has exactly one ApoB proteinProtein is the nutrient your body uses to build and repair muscle and tissue. on it. This makes ApoB a much more accurate way to count the “particle burdenParticle burden refers to the total number of atherogenic lipoprotein particles circulating in the plasma, best measured by ApoB; it is distinguished from cholesterol mass because it is the physical count of particles — not the amount of cholesterol they carry — that determines how frequently lipoproteins infiltrate and become entrapped in the arterial wall.”—the actual number of things that can get stuck in your heart’s pipes.

The Power of Time (ApoB-YearsApoB-years is a proposed research metric that represents cumulative apolipoprotein B exposure over time, expressed as the area under the apoB-versus-age curve in mg/dL·years; it is intended to capture integrated atherogenic particle burden more directly than any single measurement, but has not yet been validated as a clinical tool or treatment threshold.): It isn’t just about how many “suitcases” you have today. It’s about how long they have been trying to get through the door. Scientists call this “ApoB-years.” Having high ApoB for 40 years is much more dangerous than having it for 5 years. It’s like a slow-dripping faucet; over many years, even a small drip can flood a basement.

LipoproteinA lipoprotein is a tiny package that carries fat and cholesterol through your bloodstream. Since fat won't dissolve in water, it needs a protein wrapper to travel. Metric What it Measures Why it Matters
LDL-C (Weight) The total mass or weight of cholesterol. Can be wrong if you have many small particles.
ApoB (Count) The actual number of “bad” particles. The strongest predictor of risk; tells you the true “burden.”
Lp(a) (Sticky) A special, extra-sticky particle. An independent risk factorA risk factor is something that raises your chance of developing a disease — high cholesterol particles, high blood pressure, smoking, diabetes, family history. that makes clots more likely.

Takeaway 3: The “Glagov Effect” – How Your Arteries Hide the Trash

Why do doctors often miss this buildup? It’s because of something called the “Glagov EffectThe Glagov effect (compensatory or outward remodeling) is the tendency of an artery to expand its outer diameter as plaque accumulates within the wall, preserving the inner lumen size and blood flow until plaque burden becomes very large; this means significant atherosclerosis can be present without causing measurable narrowing on a standard angiogram..”

Think of your artery like a walk-in closet. As you start to shove more and more “junk” (plaquePlaque is the buildup of cholesterol, immune cells, scar tissue, and calcium inside an artery wall.) into the closet, you don’t just let it block the door right away. Instead, you push the back wall of the closet out further into the next room. To someone looking through the doorway, the closet looks empty and clear. But in reality, the walls are bulging with hidden junk.

Your arteries do the same thing. When plaque builds up, the outer layer of the artery wall actually stretches outward. This keeps the “hallway” (where the blood flows) wide open.

Analysis and Reflection: This is why standard tests like angiogramsAn angiogram is a test where doctors thread a thin tube into your arteries and inject dye, so the inside of the arteries shows up on an X-ray. fail us. They only look at the open space where blood flows. They cannot see the plaque hidden inside the “bulging” walls. In fact, your arteries can be 40% full of plaque before the blood flow even starts to slow down. By the time a standard test sees a “clog,” the disease has been growing for decades. We have been looking at the “hallway” while the “walls” are filled with trash.

Takeaway 4: Why a “Zero” Calcium Score Isn’t a “Get Out of Jail Free” Card

Many people get a test called a Coronary Artery Calcium (CAC)Coronary artery calcium is a measure of calcified plaque deposits in the walls of the coronary arteries, quantified by CT scan and expressed as an Agatston score; higher scores indicate greater cumulative plaque burden and predict future cardiovascular events. score. This test looks for “hard” plaque—plaque that has turned into calcium, which is like bone. If your score is zero, you might think you have zero risk.

But a “zero” score does not mean you have zero plaque. It just means you don’t have calcified plaque.

The Healing Paradox: This is the part that surprises many people. Calcium is actually a sign of “plaque healing.” It is like a scar that the body uses to cover a wound. When the body sees a mess in the artery, it tries to “stone it over” to make it stable.

  1. Hard Plaque: This is old, scarred, and calcified. It is the body’s way of trying to fix the problem.
  2. Soft PlaqueAtherosclerotic deposits within artery walls that have not yet undergone calcification; sometimes called 'soft' plaque, these lesions are lipid-rich and structurally unstable, making them more prone to rupture and acute thrombosis than calcified plaque.: This is young, “greasy” plaque. It is much more dangerous because it is “biologically active” and unstable.

Think of soft plaque like a pimple. If it “pops” (ruptures), it causes a sudden blood clotA blood clot is a clump of blood cells and protein that forms to stop bleeding., which leads to a heart attackA heart attack happens when blood flow to part of the heart muscle is cut off and that muscle starts to die.. Hard plaque is actually less likely to pop. Data shows that 25% to 30% of heart attacks happen to people who had a calcium scoreA coronary artery calcium score, or CAC score, comes from a quick CT scan that measures how much hardened plaque is in your heart's arteries. No dye, no needles, about ten minutes. of zero.

Analysis and Reflection: A zero score is better than a high score, but it is a “snapshot in time.” It shows you where the body has already created scars. It tells you nothing about the “soft grease” currently building up in your walls. For someone with high ApoB, a zero score usually just means the damage hasn’t turned to “stone” yet. The fire is still burning; it just hasn’t left any ashes for the scan to see.

Takeaway 5: AI is Smarter Than the Human Eye

Doctors are very smart, but they are limited by what the human eye can see on a screen. New technology called “AI-QCT” (like the Cleerly platform) is changing the game. This technology uses Artificial Intelligence to look at heart scans much more closely than a human can.

In a study of 750 patients, doctors looked at scans and identified 159 people they thought had “no plaque” at all. They looked “clean.” However, when the AI looked at the exact same scans, it found that many of those people actually had hidden plaque.

  • Human Eye: 159 people were told they had “no plaque.”
  • AI Eye: Only 58 of those people actually had no plaque.

The AI found that 101 people whom doctors thought were “clean” actually had non-calcified plaque (the dangerous “soft” kind). The AI can “quantify” (measure the exact amount) and “characterize” (see what it’s made of) the plaque better than a human. It shows that standard visual checks by doctors almost always miss how much disease is actually there.

Takeaway 6: The “MINOCA” Warning – Heart Attacks Without Blockages

We often think a heart attack only happens when a pipe is 100% blocked, like a clogged drain in a sink. But there is a condition called “MINOCA.” This happens when someone has a heart attack even though their pipes look wide open.

This accounts for about 5% to 15% of all heart attacks.

How does this happen? It happens because even a small, “soft” bump of plaque can tear. When that happens, the body tries to fix the tear by forming a blood clot. That clot is what stops the heart, even if the artery itself looked “open” just moments before.

Analysis and Reflection: This is the most frightening part of the “illusion.” You could have a “normal” report on Monday and a heart attack on Tuesday because a tiny, hidden bump of soft plaque decided to pop. Imagine the fear of a patient being told their “pipes are clear” only to end up in the emergency room a week later. This is why keeping your “particle count” (ApoB) low is the best defense. The fewer “suitcases” you have, the less likely you are to have one of these small but deadly “bumps” form in the first place.

Summary: Beyond the Illusion

We need to stop thinking about heart disease as a “clogged pipe” problem that only happens to old people. Instead, we need to see it as a lifelong process of “particle buildup.”

The “Clean Artery” illusion happens because our tools are often not powerful enough to see the early stages of the disease. We might have wide-open “hallways” in our arteries, but the “walls” could be filled with decades of hidden plaque.

Age vs. Plaque: The Reality Gap

Age Group “Clean” results on Clinical Scans Likely “Pristine” Arteries in Reality (Autopsy)
61–75 Years 28% to 40% of people look “clean” ~0% (Almost nobody is truly clean)
75–85 Years 10% to 20% of people look “clean” ~0% (Almost nobody is truly clean)
90+ Years ~5% of people look “clean” ~0% (Almost nobody is truly clean)

Final Thought: Next time you talk to your doctor about your heart, don’t just settle for a “normal” report. You should ask a deeper question: “Doctor, my tests look normal, but what is my ApoB count, and how do we know I don’t have hidden soft plaque?” Understanding your true “particle burden” and the hidden state of your artery walls could save your life by spotting the danger before the “illusion” disappears.

Deep Dive

Apolipoprotein B, Imaging Resolution, and the Illusion of “Normal” Coronary Arteries at Age 60

The clinical assertion that individuals maintaining markedly elevated levels of low-density lipoproteinA lipoprotein is a tiny package that carries fat and cholesterol through your bloodstream. Since fat won't dissolve in water, it needs a protein wrapper to travel. cholesterolCholesterol is a waxy substance your body needs. It goes into cell walls, hormones, vitamin D, and the bile that digests your food. You would die without it. (LDL-C) and apolipoproteinAn apolipoprotein is a protein attached to a fat-carrying particle in your blood. Fat and water don't mix, so these proteins act like a wrapper that lets fat travel safely through the bloodstream. B (ApoBApoB is a protein that sits on the outside of every cholesterol particle that can get stuck in your artery wall and cause plaque. Each of those particles carries exactly one ApoB.) can possess anatomically “normal” coronary arteriesThe coronary arteries are the small vessels that wrap around the outside of your heart and feed the heart muscle itself. at age 60 represents a diagnostic paradox. This phenomenon often hinges on the resolution of the imaging tool used. While contemporary tools like the Coronary Artery Calcium (CAC)Coronary artery calcium is a measure of calcified plaque deposits in the walls of the coronary arteries, quantified by CT scan and expressed as an Agatston score; higher scores indicate greater cumulative plaque burden and predict future cardiovascular events. score and standard visual Coronary Computed TomographyComputed tomography, or CT, takes X-ray images from many angles and reconstructs them into cross-sections of the body. Angiography (CCTA) provide a high-resolution window into the arterial wall, they exist in tension with pathological evidence which suggests that atherosclerosisAtherosclerosis is the disease behind most heart attacks and many strokes. Cholesterol particles get stuck in the wall of an artery, the body sends immune cells to clean up, and over years that mess hardens into plaque. is a nearly universal condition of human aging, and clinical data showing that heart attacksA heart attack happens when blood flow to part of the heart muscle is cut off and that muscle starts to die. can occur even in the absence of significant anatomical blockages [1].

The Causal Framework of Lipoprotein-Driven Atherogenesis

The consensus establishes that prolonged exposure to ApoB-containing lipoproteins is the primary driver of atherosclerotic plaquePlaque is the buildup of cholesterol, immune cells, scar tissue, and calcium inside an artery wall. [2]. Each atherogenic particleAtherogenic particles are the ApoB-containing lipoproteins—including LDL, IDL, VLDL, and lipoprotein(a)—that can enter and be retained in the artery wall to initiate and sustain plaque growth; the article uses the term to describe what must be lowered substantially and sustainably to achieve plaque regression.—including LDLLDL, or low-density lipoprotein, is the main particle that carries cholesterol through your blood — and the main one that gets stuck in artery walls., VLDLVLDL, or very-low-density lipoprotein, is the particle your liver makes to ship triglycerides out to the rest of the body., and IDLIDL, or intermediate-density lipoprotein, is a particle that forms partway through the process of a big triglyceride-carrying particle shrinking down into an LDL particle.—carries a single molecule of ApoB, making it a direct measure of the total number of circulating particles that can penetrate the arterial wall [2]. The probability of a particle becoming trapped in the subendothelial spaceThe subendothelial space is the narrow gap just beneath the artery's inner lining, between that single layer of cells and the muscle beneath. is a function of both particle concentration and the duration of exposure, often quantified as “ApoB-yearsApoB-years is a proposed research metric that represents cumulative apolipoprotein B exposure over time, expressed as the area under the apoB-versus-age curve in mg/dL·years; it is intended to capture integrated atherogenic particle burden more directly than any single measurement, but has not yet been validated as a clinical tool or treatment threshold.” [2].

While LDL-C measures the mass of cholesterol, ApoB reflects the particle burdenParticle burden refers to the total number of atherogenic lipoprotein particles circulating in the plasma, best measured by ApoB; it is distinguished from cholesterol mass because it is the physical count of particles — not the amount of cholesterol they carry — that determines how frequently lipoproteins infiltrate and become entrapped in the arterial wall. [3]. In cases of discordanceSee ApoB Discordance for the full entry.—where ApoB is high but LDL-C is relatively lower—ApoB remains the more accurate predictor of future myocardial infarctionSee Heart Attack for the full entry. (MI) and clinical events [4].

Lipoprotein Metrics

Lipoprotein Metric Definition and Pathological Role Association with Plaque BurdenPlaque burden is the total amount of plaque in your arteries, everywhere — not just at the single worst spot.
Low-Density Lipoprotein Cholesterol (LDL-C) The mass of cholesterol contained within LDL particles Causal, but may be discordant with particle count [3]
Apolipoprotein B (ApoB) A structural proteinProtein is the nutrient your body uses to build and repair muscle and tissue.; one exists on every atherogenic particle Strongest predictor of risk; reflects true particle burden [3]
Lipoprotein(a)Lipoprotein(a), written Lp(a) and said "L-P-little-a," is an LDL-like particle with an extra sticky protein attached. [Lp(a)] An LDL-like particle with an additional protein [apo(a)] Independent risk factorA risk factor is something that raises your chance of developing a disease — high cholesterol particles, high blood pressure, smoking, diabetes, family history.; promotes calcificationCalcification is when calcium gets deposited into a plaque, turning part of it hard and bony. and thrombosisThrombosis is a blood clot forming inside a blood vessel. [5]

Forensic vs. Clinical Reality: The “Pristine” Artery Illusion

The claim that an individual can reach age 60 without “arterial damage” is often a result of clinical imaging failing to detect microscopic disease. Forensic autopsy studies, including the Pathobiological Determinants of Atherosclerosis in Youth (PDAYPDAY, short for Pathobiological Determinants of Atherosclerosis in Youth, examined the arteries of young people aged 15 to 34 who died of other causes.) and the Bogalusa Heart StudyThe Bogalusa Heart Study examined the arteries of children and young adults who died in accidents in a Louisiana town., demonstrate that microscopic fatty streaksA fatty streak is the earliest visible stage of atherosclerosis — a flat yellow smear of cholesterol-filled immune cells just under the artery lining.—the earliest macroscopic evidence of atherosclerosis—are present in nearly all adolescents examined [6].

By the sixth decade of life, pathologically pristine coronary arteries are virtually absent in Westernized populations. Diffuse intimal thickeningIntimal thickening is an early adaptive or pathological increase in the thickness of the innermost layer of an artery (the intima), which can reflect either normal developmental changes or the accumulation of smooth muscle cells, lipids, and inflammatory cells that precede overt plaque formation. It is measurable non-invasively by carotid intima-media thickness ultrasound. and lipid deposition become ubiquitous by midlife, and contemporary autopsy cohorts report coronary atherosclerosis in nearly all adults by the fourth decade [6].

The Glagov Effect: How Arteries Hide Plaque Burden

A critical contributor to “normal” coronary imagingNon-invasive or invasive techniques—such as quantitative coronary angiography or intravascular ultrasound—used to visualise the size and character of plaques inside the coronary arteries; the Ornish and Esselstyn work is notable for using objective coronary imaging rather than relying solely on symptom or event data. is the Glagov phenomenonThe Glagov phenomenon (also called compensatory or outward remodeling) is the tendency of an arterial wall to expand outward as atherosclerotic plaque accumulates, thereby preserving the inner lumen diameter until plaque burden becomes very large. Because lumen size stays normal during this compensatory phase, standard stress tests and angiograms can appear normal even in the presence of substant…, or compensatory outward remodelingThe process by which an artery expands its outer diameter to preserve luminal blood flow as plaque accumulates within the vessel wall; luminal narrowing is typically delayed until plaque occupies roughly 40% of the internal elastic lamina area, making early disease invisible to lumen-focused imaging. [7]. As plaque accumulates within the arterial wall, the vessel expands externally to preserve luminal diameter and maintain blood flow [7]. Hemodynamically significant luminal narrowing is typically delayed until plaque burden exceeds approximately 40% of the internal elastic lamina area [7].

Because standard invasive angiography and conventional visual CCTA focus primarily on the lumenThe lumen is the open channel inside a blood vessel where blood actually flows., substantial plaque burden may exist within the vessel wall while remaining angiographically invisible [7]. These concealed plaques are often lipid-rich and biologically active, rendering them prone to erosion or rupture capable of precipitating MI even in the absence of pre-existing stenosisStenosis is narrowing — usually described as a percentage, like a 70 percent blockage. [1].

AI-QCT (Cleerly) vs. Standard Visual Interpretation

Artificial Intelligence–Quantitative Computed Tomography (AI-QCT) platforms, such as Cleerly, have demonstrated that standard visual interpretation of CCTA systematically underestimates plaque burden [8]. By enabling volumetric plaque quantificationA computational technique, employed by AI-QCT platforms such as Cleerly, that measures the three-dimensional volume and composition of coronary plaque from CT data rather than relying on visual estimation of lumen narrowing. and compositional analysis, AI-QCT achieves accuracy approaching invasive intravascular ultrasoundIntravascular ultrasound, or IVUS, uses a tiny ultrasound probe threaded inside a coronary artery to photograph the wall from within. [8].

In a cohort of approximately 750 patients, AI-QCT analysis led to diagnostic modification in 39% of cases, while the number of patients classified as having “no plaque” fell from 159 to 58 following quantitative assessment [8]. These findings confirm that visually “normal” coronary CT angiogramsAn angiogram is a test where doctors thread a thin tube into your arteries and inject dye, so the inside of the arteries shows up on an X-ray. frequently harbor clinically relevant non-calcified plaqueNon-calcified plaque is the soft, fatty portion of a plaque that has not hardened with calcium. It shows up dark on a CT scan..

Coronary Artery Calcium Score and Myocardial Infarction Risk

Coronary ArteryAn artery is a blood vessel that carries blood away from the heart to the rest of the body. Calcium scoring is a powerful population-level risk stratification tool, but its relationship with individual myocardial infarction risk is probabilistic rather than absolute. Large prospective cohortsA prospective cohort enrolls healthy people, records their characteristics, and then waits to see what happens., including the Multi-Ethnic Study of Atherosclerosis (MESA)A large prospective cohort study of adults initially free of cardiovascular disease that has provided foundational data on coronary artery calcium scoring, demonstrating a strong graded association between CAC burden and future coronary events and validating the risk implications of a CAC score of zero., demonstrate a strong graded association between CAC burden and future coronary heart diseaseCoronary heart disease is the narrowing or blockage of the arteries that supply blood to the heart muscle, caused by the buildup of atherosclerotic plaque; it is the leading cause of heart attack and cardiac death worldwide. events, with markedly elevated risk observed at scores ≥300 [11].

However, a CAC score of zero does not confer immunity from MI. Although short-term event rates are low, non-calcified, lipid-rich plaquesAn atherosclerotic lesion whose core is dominated by cholesterol esters and inflammatory lipids rather than calcium or fibrous tissue; the article notes that such plaques are highly responsive to intensive treatment and that the dramatic 65-percentage-point regression at the diagonal branch origin is consistent with reversal of a lipid-rich lesion.—particularly in individuals with elevated ApoB—remain capable of rupture or erosion [12]. Approximately 25–30% of acute coronary syndromesAcute coronary syndrome (ACS) is the umbrella term for any sudden drop in blood flow to the heart — from unstable angina to a full heart attack — caused by a plaque suddenly rupturing or eroding. occur in individuals with absent or minimal coronary calcification at baseline, reflecting the temporal disconnect between plaque formation, calcification, and plaque instability [12]. Calcification is increasingly recognized as a marker of plaque chronicityThe concept that calcification within atherosclerotic plaque reflects older, more stable disease that has undergone fibrous and calcium deposition over time, rather than active, vulnerable disease; it is why high calcium scores indicate cumulative long-term burden rather than imminent rupture risk. and healing rather than vulnerability, whereas non-calcified plaque burden correlates more closely with near-term risk.

Thus, CAC scoring is best interpreted as a measure of cumulative plaque burden and long-term risk rather than as a detector of biologically active atherosclerosis. In high–ApoB individuals, a CAC score of zero more likely reflects delayed disease expression than true disease absence.

MI Risk With “Near-Zero” Plaque Burden: The MINOCA Syndrome

Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA) accounts for approximately 5–15% of all acute myocardial infarctions [1]. Even small, non-obstructive plaquesAtherosclerotic plaque that occupies less than 50% of the coronary artery lumen, allowing blood to flow normally and typically producing no symptoms on standard stress testing; it is nonetheless the source of the majority of myocardial infarctions when it ruptures. may undergo endothelial erosion, triggering localized thrombosis without angiographically visible obstruction [9].

Importantly, ApoB remains a strong independent predictorA variable that statistically forecasts an outcome—such as mortality—even after accounting for other known risk factors like age, BMI, and cholesterol through multivariable analysis. of MI risk even among individuals without obstructive coronary disease, as demonstrated in large population cohorts and randomized lipid-lowering trials [4].

Longitudinal Data: Prevalence of Zero Plaque From 60 to 100 Years

Despite near-universal atherosclerosis on pathological examination, clinical imaging registries identify a subset of individuals who maintain zero coronary calcification into advanced age [10].

Age Group (Years) Prevalence of CAC = 0 (Clinical Imaging) Likelihood of Truly “Pristine” Arteries (Autopsy)
61–75 28%–40% ~0%
75–85 10%–20% ~0%
≥90 ~5% ~0%

In the oldest old, a so-called “cholesterol paradox” has been observed, wherein higher LDL-C levels (≥130 mg/dL) are sometimes associated with longer survival, likely reflecting survival bias or age-dependent protective roles of cholesterol in immune function and cellular repair [10].

References

  1. Tamis-Holland JE, Jneid H, Reynolds HR, et al. Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease: A Scientific Statement From the American Heart Association. Circulation. 2019;139(18):e891-e908. doi:10.1161/CIR.0000000000000670
  2. Ference BA, Ginsberg HN, Graham I, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38(32):2459-2472. doi:10.1093/eurheartj/ehx144
  3. Sniderman AD, Thanassoulis G, Glavinovic T, et al. Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review. JAMA Cardiol. 2019;4(12):1287-1295. doi:10.1001/jamacardio.2019.3780
  4. Marston NA, Giugliano RP, Melloni GEM, et al. Association of Apolipoprotein B-Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis: Distinguishing Between Particle Concentration, Type, and Content. JAMA Cardiol. 2022;7(3):250-256. doi:10.1001/jamacardio.2021.5083
  5. Tsimikas S. A Test in Context: Lipoprotein(a): Diagnosis, Prognosis, Controversies, and Emerging Therapies. J Am Coll Cardiol. 2017;69(6):692-711. doi:10.1016/j.jacc.2016.11.042
  6. Strong JP, Malcom GT, McMahan CA, et al. Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. JAMA. 1999;281(8):727-735. doi:10.1001/jama.281.8.727
  7. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med. 1987;316(22):1371-1375. doi:10.1056/NEJM198705283162204
  8. Nurmohamed NS, Cole JH, Budoff MJ, et al. Impact of atherosclerosis imaging-quantitative computed tomography on diagnostic certainty, downstream testing, coronary revascularization, and medical therapy: the CERTAIN study. Eur Heart J Cardiovasc Imaging. 2024;25(6):857-866. doi:10.1093/ehjci/jeae029
  9. Agewall S, Beltrame JF, Reynolds HR, et al. ESC working group position paper on myocardial infarction with non-obstructive coronary arteries. Eur Heart J. 2017;38(3):143-153. doi:10.1093/eurheartj/ehw149
  10. Mortensen MB, Nordestgaard BG. Elevated LDL cholesterol and increased risk of myocardial infarction and atherosclerotic cardiovascular disease in individuals aged 70-100 years: a contemporary primary prevention cohort. Lancet. 2020;396(10263):1644-1652. doi:10.1016/S0140-6736(20)32233-9
  11. Budoff MJ, Shaw LJ, Liu ST, et al. Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J Am Coll Cardiol. 2007;49(18):1860-1870. doi:10.1016/j.jacc.2006.10.079
  12.  Blaha MJ, Cainzos-Achirica M, Greenland P, et al. Role of Coronary Artery Calcium Score of Zero and Other Negative Risk Markers for Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2016;133(9):849-858. doi:10.1161/CIRCULATIONAHA.115.018524

Transparency Note: This blog post was created with assistance from AI tools. The final content has been carefully reviewed and edited by the author, who is responsible for its accuracy. The information provided is for educational purposes only and does not constitute medical advice.

AI App

Heart Risk Calulator

Educational family-history heart risk calculator with H-score insights, visual family tree input and shareable PDF reports.

Read why this app is so important here.